SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029316
Filing Date
2018-11-13
Accepted
2018-11-13 16:18:55
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cue-10q_20180930.htm 10-Q 1008773
2 EX-31.1 cue-ex311_10.htm EX-31.1 18369
3 EX-31.2 cue-ex312_6.htm EX-31.2 18136
4 EX-32.1 cue-ex321_9.htm EX-32.1 11291
5 GRAPHIC gxt2prdv00k4000001.jpg GRAPHIC 29831
  Complete submission text file 0001564590-18-029316.txt   4094291

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cue-20180930.xml EX-101.INS 735345
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20180930.xsd EX-101.SCH 43513
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cue-20180930_cal.xml EX-101.CAL 37378
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cue-20180930_def.xml EX-101.DEF 108704
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20180930_lab.xml EX-101.LAB 309317
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20180930_pre.xml EX-101.PRE 227912
Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 181178219
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1